Evidence map›Paper›PMID 35276765›Full record

ArticleNutrients2022

d-Allulose Improves Endurance and Recovery from Exhaustion in Male C57BL/6J Mice.

Bingyang Liu, Yang Gou, Takamasa Tsuzuki, Takako Yamada, Tetsuo Iida, Sixian Wang, Ryoichi Banno, Yukiyasu Toyoda, Teruhiko Koike

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Bingyang LiuDepartment of Sports Medicine, Graduate School of Medicine, Nagoya University, Nagoya 464-8601, Japan.ORCID 0000-0003-4581-8570
Yang GouDepartment of Sports Medicine, Graduate School of Medicine, Nagoya University, Nagoya 464-8601, Japan.
Takamasa TsuzukiFaculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan.ORCID 0000-0002-0241-1183
Takako YamadaResearch and Development, Matsutani Chemical Industry Co. Ltd., Itami 664-8508, Japan.ORCID 0000-0002-0181-7093
Tetsuo IidaResearch and Development, Matsutani Chemical Industry Co. Ltd., Itami 664-8508, Japan.ORCID 0000-0001-5028-2446
Sixian WangDepartment of Sports Medicine, Graduate School of Medicine, Nagoya University, Nagoya 464-8601, Japan.
Ryoichi BannoDepartment of Sports Medicine, Graduate School of Medicine, Nagoya University, Nagoya 464-8601, Japan.
Yukiyasu ToyodaFaculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan.
Teruhiko KoikeDepartment of Sports Medicine, Graduate School of Medicine, Nagoya University, Nagoya 464-8601, Japan.ORCID 0000-0003-3809-499X
Nagoya University · JPMatsutani (Japan) · JPMeijo University · JP

Funding

Japanese Ministry of Education, Science, Sports, and Culture 20K11386
6 · The paper itself

Abstract

d-Allulose, a rare sugar, improves glucose metabolism and has been proposed as a candidate calorie restriction mimetic. This study aimed to investigate the effects of d-allulose on aerobic performance and recovery from exhaustion and compared them with the effects of exercise training. Male C57BL/6J mice were subjected to exercise and allowed to run freely on a wheel. Aerobic performance was evaluated using a treadmill. Glucose metabolism was analyzed by an intraperitoneal glucose tolerance test (ipGTT). Skeletal muscle intracellular signaling was analyzed by Western blotting. Four weeks of daily oral administration of 3% d-allulose increased running distance and shortened recovery time as assessed by an endurance test. d-Allulose administration also increased the maximal aerobic speed (MAS), which was observed following treatment for >3 or 7 days. The improved performance was associated with lower blood lactate levels and increased liver glycogen levels. Although d-allulose did not change the overall glucose levels as determined by ipGTT, it decreased plasma insulin levels, indicating enhanced insulin sensitivity. Finally, d-allulose enhanced the phosphorylation of AMP-activated protein kinase and acetyl-CoA carboxylase and the expression of peroxisome proliferator-activated receptor γ coactivator 1α. Our results indicate that d-allulose administration enhances endurance ability, reduces fatigue, and improves insulin sensitivity similarly to exercise training. d-Allulose administration may be a potential treatment option to alleviate obesity and enhance aerobic exercise performance.

Indexed as

FructoseInsulin ResistanceAnimalsGlucose Tolerance TestMaleMiceMice, Inbred C57BLFructosepsicoseaerobic performanceblood lactated-alluloseglycogenmaximal aerobic speedrecoveryskeletal muscle

Identifiers

PMID35276765
PMCPMC8838150
OpenAlexW4206828898

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.